SSDP Australia: How is the World Health Organisation facilitating meaningful inclusion of people who use drugs in the design and implementation of policies and strategies around existing and emerging pharmacotherapies at the global level? WHO: The principle of involving affected groups in the development of guidance is strong. To develop WHO guidelines on managing health …
International Association for Hospice and Palliative Care (IAHPC)
Item 5. Implementation of the international drug control treaties (Monday afternoon)
(c) International Narcotics Control Board Colombia: (TBA) Pakistan: Pakistan acknowledges and appreciates the effective role and efforts of the INCB in the collection of data, in-depth analysis, and compilation of the comprehensive report. We believe that the INCB report for 2023 will provide assistance to member states in aligning their national priorities and responses to …
Side event: Taking the Pledge4Action to ensure adequate availability of internationally controlled essential medicines
The 50-minute side event was sponsored by the Kingdom of Belgium and hosted by the International Association for Hospice and Palliative Care. Co-sponsors were Dianova, CAPSA, INCB, Pallium India, Union for International Cancer Control, Vienna NGO Committee on Drugs, and the Worldwide Hospice Palliative Care Alliance. Professor Dr Dr Charlotte Colman, Professor Drug Policy and …
CND Reconvened 66th Session
Chair: Good Morning. The focus of our discussion pertains to Strategic Management budgetary and administrative motions in the context of our economy. Yesterday, in collaboration with the CCP CJ, we deliberated on the Consolidated budget for the biennium 2024-2025 for the United Nations Office on Drugs and Crime, referencing Containers document 5.2 (2013) and 15/2017, …
CND Thematic Discussion / Session 11 – Low availability of internationally controlled substances for medical & scientific purposes
Chair: Good Morning. Yesterday we had a fruitful discussion on the issues of the consequences and risk associated with non medical use of drugs. Today we will be discussing the low availability of nationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care. Before we start a discussion, …
Side event. Innovation responses to promoting access to controlled medicines, while preventing diversion and non-medical use: Following up on the global “access and availability” campaign led by the chair of the 65th CND
Organised by Belgium with the support of Australia, Austria, Bulgaria, Croatia, Cyprus, Czechia, Denmark, El Salvador, Estonia, Finland, France, Germany, Ghana, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, the United States, the European Union, the UNODC Prevention, Treatment and Rehabilitation Section, the …